ArticleMolecules (Basel, Switzerland)2025
Design, Synthesis, and Antitumor Biological Evaluation of Galaxamide and Its Analogs.
Yanyan Guo, Huixia Fan, Zhiqiang Luo, Jian Yang, Guodu Liu
Abstract read
In one paragraphArticle in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors.
Yanyan GuoInner Mongolia Key Laboratory of Synthesis and Application of Organic Functional Molecules, College of Chemistry and Chemical Engineering, Inner Mongolia University (South Campus), 24 Zhaojun Road, Hohhot 010030, China.
Huixia FanState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-Di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Zhiqiang LuoState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-Di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.ORCID 0000-0002-5888-9522 Jian YangState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-Di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.ORCID 0000-0002-2273-4510 Guodu LiuInner Mongolia Key Laboratory of Synthesis and Application of Organic Functional Molecules, College of Chemistry and Chemical Engineering, Inner Mongolia University (South Campus), 24 Zhaojun Road, Hohhot 010030, China.ORCID 0000-0002-1249-0313 Funding
"Grassland Talents" Program of Inner Mongolia 12000-12102414, 12000-12102810, 21300-242927Industrial Technology Innovation Program of IMAST 2022CYCX02002"JUN-MA" High-level Talents Program of Inner Mongolia University 21300-5185121, 10000-21311201/136National Natural Science Foundation of China 22061032Natural Science Foundation of Inner Mongolia 2020MS02022Science and Technology Program of Inner Mongolia 2020GG0134Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences CI2023E002, CI2021B009
6 · The paper itselfAbstract
Indexed as
Antineoplastic AgentsDrug DesignPeptides, CyclicA549 CellsCell Line, TumorCell ProliferationDrug Screening Assays, AntitumorHEK293 CellsHumansK562 CellsLeucineMolecular StructureStructure-Activity RelationshipAntineoplastic AgentsLeucinePeptides, Cyclicantitumor agentcyclopeptidegalaxamideliquid-phase peptide synthesismarine natural product
Identifiers
PMID40509249
PMCPMC12155888
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390